Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP

, operates the business of manufacturing and distribution of dialysis and medical equipment, later in February 2018, NCLpurchased some shares from a shareholder, making it the major shareholder with 52.80% of

Pandemic, the capacity utilization increase was deferred. IRSL manufacturing facility is located in Butibori near Nagpur, State of Maharashtra, India. Currently, there is complete lockdown in the state of

, the EOEG facility enjoyed better margin and normal volume following a planned turnaround for catalyst change in 2Q17. There was minor impact of Hurricane Harvey leading to short-term shutdown of EOEG

from the 1Q19 catalyst turnaround at our EO-EG facility in USA and due to the plummeting MEG margins in Asia although cushioned by the lower cost USGC economics. On the other hand, our Purified EO (PEO

impacted our EOEG facility at Clear Lake, Texas and lowered HVA and Necessity production by over 45KT during a strong margin environment. Since startup, the plant is performing well into 3Q17 with margins

addition, the economic impact of Covid-19 will be only fully visible in the Q2-Q4 period of the year. However, as our business is essential to many manufacturing processes, and as we are quite diversified

is likely leaving its mark on the Thai economy. Private consumption growth moderated noticeably in Q1 while private investment fell, reflecting dampening domestic demand. Manufacturing output

manufacturing cosmeceuticals and modern medicine from FDA and controlled quality and operational efficiency which certified by international standards ISO 9001:2008, GMP, PICS, HACCP และ HALAL. Presently, At-Ze

located in Muang district, Chachoengsao province and authorized manufacturing cosmeceuticals and modern medicine from FDA and controlled quality and operational efficiency which certified by international